Harbin Pharmaceutical Group

GPTKB entity

Statements (55)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition various international pharmaceutical companies
gptkbp:awards gptkb:National_Quality_Award
Top 100 Pharmaceutical Companies in China
gptkbp:category gptkb:traditional_Chinese_medicine
medical devices
biological products
chemical drugs
gptkbp:CEO gptkb:Zhang_Jian
gptkbp:certifications ISO certification
GMP_certification
gptkbp:clinicalTrials various drug candidates
gptkbp:collaborations hospitals
academic institutions
research organizations
healthcare_providers
gptkbp:community_engagement educational initiatives
local health programs
gptkbp:community_outreach health fairs
screening programs
health education workshops
gptkbp:employees over 10,000
gptkbp:exportMarkets gptkb:Asia
gptkb:North_America
Europe
gptkbp:financialPerformance dividend payments
strong market presence
consistent growth
gptkbp:founded 1994
gptkbp:future_plans expansion into new markets
development of new therapies
increased R&D investment
gptkbp:headquarters gptkb:Harbin,_China
https://www.w3.org/2000/01/rdf-schema#label Harbin Pharmaceutical Group
gptkbp:industry pharmaceuticals
gptkbp:investmentFocus biotechnology startups
gptkbp:market gptkb:China
gptkbp:partnerships global pharmaceutical firms
gptkbp:patentCitation numerous pharmaceutical patents
gptkbp:products medications
gptkbp:research_focus oncology
neurological disorders
cardiovascular diseases
infectious diseases
gptkbp:researchAndDevelopment biopharmaceuticals
gptkbp:revenue over 1 billion USD
gptkbp:social_responsibility environmental sustainability programs
healthcare_initiatives
gptkbp:stockExchange gptkb:Shenzhen_Stock_Exchange
000663
gptkbp:subsidiary gptkb:Harbin_Pharmaceutical_Group_Co.,_Ltd.
gptkbp:sustainability_initiatives energy efficiency projects
waste reduction programs
green manufacturing practices
gptkbp:website www.hbpharm.com